WallStreetZenWallStreetZen

NASDAQ: ALXO
Alx Oncology Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ALXO past revenue growth

How has ALXO's revenue growth performed historically?
Company
N/A
Industry
143.99%
Market
17.8%
ALXO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ALXO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ALXO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$160.8M
Current Profit Margin
0%

ALXO Return on Equity

Current Company
-79.3%
Current Industry
-63.5%
Current Market
188%
ALXO's Return on Equity (-79.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ALXO announces earnings.

ALXO Return on Assets

Current Company
-65.2%
Current Industry
2.9%
ALXO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALXO Return on Capital Employed

Current Company
-77.09%
Current Industry
19.5%
ALXO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALXO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALXO$0.00-$158.40M-$160.81M-100.00%N/A
SLN$32.12M-$60.37M-$54.77M+216.26%N/A
ARQT$59.61M-$227.43M-$262.14M+1,517.09%N/A
VRDN$314.00k-$235.32M-$237.73M-48.16%N/A
RLAY$25.55M-$336.70M-$341.97M-88.41%N/A
View Top Biotech Stocks

ALXO earnings dates

Next earnings date
Jun 12, 2024

Alx Oncology Holdings Earnings & Revenue FAQ

What were ALXO's earnings last quarter?

On Invalid Date, Alx Oncology Holdings (NASDAQ: ALXO) reported Q4 2023 earnings per share (EPS) of -$0.92, up 22.67% year over year. Total Alx Oncology Holdings earnings for the quarter were -$45.47 million. In the same quarter last year, Alx Oncology Holdings's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Alx Oncology Holdings stock.

What was ALXO's earnings growth in the past year?

As of Q2 2024, Alx Oncology Holdings's earnings has grown year over year. Alx Oncology Holdings's earnings in the past year totalled -$160.81 million.

What is ALXO's earnings date?

Alx Oncology Holdings's earnings date is Invalid Date. Add ALXO to your watchlist to be reminded of ALXO's next earnings announcement.

What was ALXO's revenue last quarter?

On Invalid Date, Alx Oncology Holdings (NASDAQ: ALXO) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Alx Oncology Holdings's revenue was $0.00.

What was ALXO's revenue growth in the past year?

As of Q2 2024, Alx Oncology Holdings's revenue has grown null year over year. Alx Oncology Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.